Effect of C-344T polymorphism of aldosterone synthase gene on variability of antihypertensive therapy with angiotensin II receptor blockers: open randomized controlled clinical trial

QR Code

Effect of C-344T polymorphism of aldosterone synthase gene on variability of antihypertensive therapy with angiotensin II receptor blockers: open randomized controlled clinical trial

The effectiveness of the antihypertensive therapy may be associated with genetic factors that affect not only the degree of a blood pressure elevation but also predetermine an interindividual variability in response to the antihypertensive treatment.The aim of the work was to study pharmacodynamic i...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. V. Rebrova, E. V. Shikh, N. B. Lazareva
Format:	Article
Language:	Russian
Published:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2024-11-01
Series:	Фармация и фармакология (Пятигорск)
Subjects:	arterial hypertension aldosterone synthase cyp11b2 c-344t polymorphism
Online Access:	https://www.pharmpharm.ru/jour/article/view/1543
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

С(-344)Т polymorphism of aldosterone synthase gene, risk of metabolic syndrome, and atrial fibrillation risk for inhabitants of the Northwest regions of Russia
by: I. Ma, et al.
Published: (2016-06-01)

Intratumoural aldosterone and CYP11B2 expression levels among different genotypes of aldosterone producing tumours
by: Tobias Åkerström, et al.
Published: (2025-06-01)

Role of renin-angiotensin-aldosterone system gene polymorphisms in the development of diastolic dysfunction in female patients with hypertension
by: Mariya A. Grenaderova, et al.
Published: (2025-01-01)

Effect of insertion/deletion polymorphism of angiotensin-converting enzyme gene on efficacy of antihypertensive therapy with angiotensin II receptor blockers
by: E. V. Rebrova, et al.
Published: (2024-01-01)

Distribution of genotypes and alleles of the aldosterone-synthase gene in patients with abdominal obesity
by: D. L. Brovin, et al.
Published: (2015-06-01)

Evaluation of the relationship between the minimum steady-state concentration of angiotensin II receptor blockers and polymorphic markers of CYP2C9 (Arg144Cys), CYP2C9 (IlE359Leu), AGTR1 (A1166C), AGT (Met235Thr, C4072T), ACE (I/D), CYP11B2 (C-344T) genes and office arterial pressure
by: E. V. Rebrova, et al.
Published: (2025-03-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension
by: O. B. Kuzmin, et al.
Published: (2024-10-01)

The effect of renin-angiotensin system blockers on aldosterone levels in patients with chronic heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2020-12-01)

POLYMORPHISM C(-344)T OF THE ALDOSTERONE SYNTHASE GENE AND ESSENTIAL ARTERIAL HYPERTENSION
by: O. S. Pavlova, et al.
Published: (2016-12-01)

Clinical pharmacogenetics of angiotensin II receptor blockers: new perspectives of pharmacotherapy individualization
by: D. A. Sychev, et al.
Published: (2006-04-01)

Polymorphisms of cytochrome genes in women with polycystic ovary syndrome
by: A. Yu. Beglova, et al.
Published: (2019-09-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
by: A. E. Bragina, et al.
Published: (2005-12-01)

The effect of the <i>M235T</i> polymorphism of the angiotensinogen gene on the office blood pressure during therapy with angiotensin II receptor blockers
by: E. V. Rebrova, et al.
Published: (2024-12-01)

THE POLYMORPHISM OF THE SUS4 SUCROSE SYNTHASE DOMAIN SEQUENCES IN RUSSIAN, BELORUSSIAN AND KAZAKH POTATO CULTIVARS
by: M. A. Slugina, et al.
Published: (2016-07-01)

SERUM ALDOSTERONE LEVEL DYNAMICS AND CARDIAC REMODELING IN MYOCARDIAL INFARCTION PATIENTS WITH UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA TREATED WITH SELECTIVE ALDOSTERONE RECEPTOR BLOCKER
by: E. P. Miroshnichenko, et al.
Published: (2018-09-01)

Allelic polymorphisms of thymidylate synthase gene and their haplotypes as predictors of the therapeutic response to methotrexate in patients with rheumatoid arthritis
by: I. V. Devald, et al.
Published: (2019-05-01)

Adipose Composition Before and After Primary Aldosteronism Treatment Depends on Primary Aldosteronism Subtypes and Plasma Aldosterone Concentration Before the Treatment
by: Eriko Nakano, et al.
Published: (2025-07-01)

Pharmacogenetic aspects of eprosartan therapy and polymorphic markers of renin-angiotensin-aldosterone system genes in Uzbek patients with essential arterial hypertension
by: D. R. Kurbanova, et al.
Published: (2009-06-01)

Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system
by: L. M. Resnick, et al.
Published: (2011-12-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

PREVALENCE OF 2756A>G POLYMORPHISM OF METHIONINE SYNTHASE GENE IN POPULATIONS OF EASTERN SIBERIA
by: K. D. Ievleva, et al.
Published: (2014-11-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2012-09-01)

The role of aldosterone in the development of atrial fibrillation: modern understanding of problem
by: N. T. Vatutin, et al.
Published: (2019-03-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015-09-01)

Blood aldosterone level in various types of atrial fibrillation
by: N. T. Vatutin, et al.
Published: (2016-02-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

Fig Wax Scale, Ceroplastes rusci (L.) (Insecta: Hemiptera: Coccoidea: Coccidae)
by: Avas B. Hamon, et al.
Published: (2004-03-01)

Fig Wax Scale, Ceroplastes rusci (L.) (Insecta: Hemiptera: Coccoidea: Coccidae)
by: Avas B. Hamon, et al.
Published: (2004-03-01)

Preoperative long-term use of renin-angiotensin-aldosterone system blockers increases the risk of acute kidney injury after coronary artery bypass grafting
by: Xiaokang Xu, et al.
Published: (2025-12-01)

PROGNOSTIC SIGNIFICANCE OF THE VNTR POLYMORPHISM INTRON 4 OF THE GENE OF NITRIC OXIDE ENDOTHELIAL SYNTHASE IN CHRONIC HEART FAILURE PATIENTS
by: E. A. Polunina, et al.
Published: (2018-02-01)

Gene polymorphism of endothelial NO-synthase, angiotensin-converting enzyme and receptors of angiotensin II type 1 in patients with coronary artery disease and type II diabetes.
by: L. M. Yakovleva
Published: (2013-12-01)

The functional state of the kallikrein-kinin and renin-angiotensin-aldosterone systems in patients with localized kidney cancer
by: N. D. Ushakova, et al.
Published: (2021-12-01)

THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

Law nº 13.344/2016 and the new techniques for the localization of human trafficking victims and suspects: effectiveness, legality and constitutional adequacy
by: Cleopas Isaías Santos, et al.
Published: (2017-06-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
by: N. V. Drobotya, et al.
Published: (2020-06-01)

Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: A call to action from the cardio-kidney community
by: Roberto Pecoits-Filho, et al.
Published: (2025-09-01)

Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community
by: Roberto Pecoits-Filho, MD, PhD, et al.
Published: (2025-07-01)

Plasma Aldosterone Elevation in Hypertensive Patients and Association with Urinary Stone Formation: A Large-Scale Population Study from Northwest China
by: Song S, et al.
Published: (2025-05-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes: the role of renin-angiotensin-aldosterone system (literature review) (part 2)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)